Document Detail


Stability of early-stage amyloid-β(1-42) aggregation species.
MedLine Citation:
PMID:  22944394     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Accumulation of aggregated amyloid-β protein (Aβ) is an important feature of Alzheimer's disease. There is significant interest in understanding the initial steps of Aβ aggregation due to the recent focus on soluble Aβ oligomers. In vitro studies of Aβ aggregation have been aided by the use of conformation-specific antibodies which recognize shape rather than sequence. One of these, OC antiserum, recognizes certain elements of fibrillar Aβ across a broad range of sizes. We have observed the presence of these fibrillar elements at very early stages of Aβ incubation. Using a dot blot assay, OC-reactivity was found in size exclusion chromatography (SEC)-purified Aβ(1-42) monomer fractions immediately after isolation (early-stage). The OC-reactivity was not initially observed in the same fractions for Aβ(1-40) or the aggregation-restricted Aβ(1-42) L34P but was detected within 1-2weeks of incubation. Stability studies demonstrated that early-stage OC-positive Aβ(1-42) aggregates were resistant to 4M urea or guanidine hydrochloride but sensitive to 1% sodium dodecyl sulfate (SDS). Interestingly, the sensitivity to SDS diminished over time upon incubation of the SEC-purified Aβ(1-42) solution at 4°C. Within 6-8days the OC-positive Aβ42 aggregates were resistant to SDS denaturation. The progression to, and development of, SDS resistance for Aβ(1-42) occurred prior to thioflavin T fluorescence. In contrast, Aβ(1-40) aggregates formed after 6days of incubation were sensitive to both urea and SDS. These findings reveal information on some of the earliest events in Aβ aggregation and suggest that it may be possible to target early-stage aggregates before they develop significant stability.
Authors:
Kelley A Coalier; Geeta S Paranjape; Sanjib Karki; Michael R Nichols
Related Documents :
24421984 - The use of platelet rich plasma, bone morphogenetic protein-2 and different scaffolds i...
23277174 - Anti-β2gp1 antibodies have variable effects on platelet aggregation.
22486984 - Platelet proteome and clopidogrel response in patients with stable angina undergoing pe...
23846224 - Ros-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte...
21881044 - Critical role for syk in responses to vascular injury.
196024 - Enhancement of the pge1 response of macrophages by concanavalin a and colchicine.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2012-08-25
Journal Detail:
Title:  Biochimica et biophysica acta     Volume:  1834     ISSN:  0006-3002     ISO Abbreviation:  Biochim. Biophys. Acta     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-12-26     Completed Date:  2013-03-18     Revised Date:  2014-01-09    
Medline Journal Info:
Nlm Unique ID:  0217513     Medline TA:  Biochim Biophys Acta     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  65-70     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier B.V. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amyloid / chemistry*
Amyloid beta-Peptides / chemistry*
Antibodies / chemistry
Guanidine / chemistry
Humans
Peptide Fragments / chemistry*
Protein Stability
Sodium Dodecyl Sulfate / chemistry
Urea / chemistry
Grant Support
ID/Acronym/Agency:
R15 AG033913/AG/NIA NIH HHS; R15AG033913/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Amyloid; 0/Amyloid beta-Peptides; 0/Antibodies; 0/Peptide Fragments; 0/amyloid beta-protein (1-42); 368GB5141J/Sodium Dodecyl Sulfate; 8W8T17847W/Urea; JU58VJ6Y3B/Guanidine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Shoulder hemiarthroplasty: outcomes and long-term survival analysis according to etiology.
Next Document:  Anticancer polysaccharides from natural resources: A review of recent research.